Malignant mesothelioma mortality --- United States, 1999-2005

Morbidity and Mortality Weekly Report

Volumn 58, Issue 15, 2009, Pages 393-396

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ASBESTOS;

ADULT; AGE; AGED; ARTICLE; CAUSE OF DEATH; FEMALE; HUMAN; MALE; MESOTHELIOMA; MIDDLE AGED; MORTALITY; OCCUPATIONAL EXPOSURE; RETROSPECTIVE STUDY; UNITED STATES;

ADULT; AGE FACTORS; AGED; ASBESTOS; CAUSE OF DEATH; FEMALE; HUMANS; MALE; MESOTHELIOMA; MIDDLE AGED; OCCUPATIONAL EXPOSURE; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 65249119302     PISSN: 01492195     EISSN: 1545861X     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Lanphear BP, Buncher CR. Latent period for malignant mesothelioma of occupational origin. J Occup Med 1992;34:718--21.
2. Occupational Safety and Health Administration. Safety and health topics: asbestos; 2009. Available at http://www.osha.gov/SLTC/asbestos.
3. Kelly TD, Matos GR. Historical statistics for mineral and material commodities in the United States. US Geological Survey data series 140. Reston, VA: US Department of the Interior, US Geological Survey; 2005. Available at http://minerals.usgs.gov/ds/2005/140.
4. Price B, Ware A. Mesothelioma trends in the United States: an update based on surveillance, epidemiology, and end results program data for 1973 through 2003. Am J Epidemiol 2004;159:107--12.
5. CDC. Work-related lung disease surveillance report 2007. Cincinnati, OH: US Department of Health and Human Services, CDC, National Institute for Occupational Safety and Health; 2008. Available at http://www.cdc.gov/niosh/docs/2008-143.
6. Environmental Protection Agency. EPA asbestos materials bans: clarification. Washington, DC: Environmental Protection Agency; 1999. Available at http://www.epa.gov/oppt/asbestos/pubs/asbbans2.pdf.
7. Martonik JF, Nash E, Grossman E. The history of OSHA's asbestos rule makings and some distinctive approaches that they introduced for regulating occupational exposure to toxic substances. AIHAJ 2001;62:208--17.
8. Gordon GJ, Jensen RV, Hsiao LL, et al. Translation of microarray data into clinically relevant cancer diagnostic tests using gene expression ratios in lung cancer and mesothelioma. Cancer Res 2002;62:4963--7.
9. CDC. Approaches to safe nanotechnology. Managing the health and safety concerns associated with engineered nanomaterials. Cincinnati, OH: US Department of Health and Human Services, CDC, National Institute for Occupational Safety and Health; 2009. Available at http://www.cdc.gov/niosh/docs/2009-125/pdfs/2009-125.pdf.
10. Takagi A, Hirose A, Nishimura T, et al. Induction of mesothelioma in p53+/- mouse by intraperitoneal application of multi-wall carbon nanotube. J Toxicol Sci 2008;33:105--16.